Swipe om te navigeren naar een ander artikel
Echocardiography is used in cardiac resynchronisation therapy (CRT) to assess cardiac function, and in particular left ventricular (LV) volumetric status, and prediction of response. Despite its widespread applicability, LV volumes determined by echocardiography have inherent measurement errors, interobserver and intraobserver variability, and discrepancies with the gold standard magnetic resonance imaging. Echocardiographic predictors of CRT response are based on mechanical dyssynchrony. However, parameters are mainly tested in single-centre studies or lack feasibility. Speckle tracking echocardiography can guide LV lead placement, improving volumetric response and clinical outcome by guiding lead positioning towards the latest contracting segment. Results on optimisation of CRT device settings using echocardiographic indices have so far been rather disappointing, as results suffer from noise. Defining response by echocardiography seems valid, although re-assessment after 6 months is advisable, as patients can show both continuous improvement as well as deterioration after the initial response. Three-dimensional echocardiography is interesting for future implications, as it can determine volume, dyssynchrony and viability in a single recording, although image quality needs to be adequate. Deformation patterns from the septum and the derived parameters are promising, although validation in a multicentre trial is required. We conclude that echocardiography has a pivotal role in CRT, although clinicians should know its shortcomings.
Ellenbogen KA, Gold MR, Meyer TE, et al. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation. 2010;122(25):2660–8. CrossRefPubMed
Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281–329. CrossRefPubMed
Russo AM, Stainback RF, Bailey SR, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Heart Rhythm. 2013;10(4):e11–58. CrossRefPubMed
Haan S de, Boer K de, Commandeur J, Beek AM, Rossum AC van, Allaart CP. Assessment of left ventricular ejection fraction in patients eligible for ICD therapy: discrepancy between cardiac magnetic resonance imaging and 2D echocardiography. Neth Heart J. 2014;22(10):449–55. PubMedCentralCrossRefPubMed
Hoffmann R, Barletta G, Bardeleben S von, et al. Analysis of left ventricular volumes and function: a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography. J Am Soc Echocardiogr. 2014;27(3):292–301. CrossRefPubMed
Saloux E, Labombarda F, Pellissier A, et al. Diagnostic value of three-dimensional contrast-enhanced echocardiography for left ventricular volume and ejection fraction measurement in patients with poor acoustic windows: a comparison of echocardiography and magnetic resonance imaging. J Am Soc Echocardiogr. 2014;27(10):1029–40. CrossRefPubMed
Van ’t Sant J, Ter Horst IA, Wijers SC, et al. Measurements of electrical and mechanical dyssynchrony are both essential to improve prediction of CRT response. J Electrocardiol. 2015;48(4):601–8. CrossRef
Brunet-Bernard A, Marechaux S, Fauchier L, et al. Combined score using clinical, electrocardiographic, and echocardiographic parameters to predict left ventricular remodeling in patients having had cardiac resynchronization therapy six months earlier. Am J Cardiol. 2014;113(12):2045–51. CrossRefPubMed
Ghani A, Delnoy PP, Adiyaman A, et al. Septal rebound stretch as predictor of echocardiographic response to cardiac resynchronization therapy. Int J Cardiol Heart Vasc. 2015;7:6.
Marechaux S, Guiot A, Castel AL, et al. Relationship between two-dimensional speckle-tracking septal strain and response to cardiac resynchronization therapy in patients with left ventricular dysfunction and left bundle branch block: a prospective pilot study. J Am Soc Echocardiogr. 2014;27(5):501–11. CrossRefPubMed
Kristiansen HM, Vollan G, Hovstad T, Keilegavlen H, Faerestrand S. The impact of left ventricular lead position on left ventricular reverse remodelling and improvement in mechanical dyssynchrony in cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging. 2012;13(12):991–1000. CrossRefPubMed
Bakos Z, Ostenfeld E, Markstad H, et al. A comparison between radial strain evaluation by speckle-tracking echocardiography and cardiac magnetic resonance imaging, for assessment of suitable segments for left ventricular lead placement in cardiac resynchronization therapy. Europace. 2014;16(12):1779–86. CrossRefPubMed
Jones S, Shun-Shin MJ, Cole GD, et al. Applicability of the iterative technique for cardiac resynchronization therapy optimization: full-disclosure, 50-sequential-patient dataset of transmitral Doppler traces, with implications for future research design and guidelines. Europace. 2014;16(4):541–50. CrossRefPubMed
Pabari PA, Willson K, Stegemann B, et al. When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximize it. Heart Fail Rev. 2011;16(3):277–90. PubMedCentralCrossRefPubMed
Sant J van ’t, Fiolet AT, Ter Horst IA, et al. Volumetric response beyond six months of cardiac resynchronization therapy and clinical outcome. PLoS One. 2015;10(5):e0124323. CrossRef
- Echocardiography and cardiac resynchronisation therapy, friends or foes?
W.M. van Everdingen
J. van ’t Sant
K. Ramdat Misier
- Bohn Stafleu van Loghum